We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Vaccine Therapy Plus Sargramostim Following Chemotherapy in Treating Patients With Stage III or Stage IV Non-Hodgkin's Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00004198
Recruitment Status : Completed
First Posted : May 21, 2004
Last Update Posted : January 17, 2018
Sponsor:
Collaborators:
National Cancer Institute (NCI)
Genitope Corporation
Information provided by (Responsible Party):
Julie M Vose, MD, University of Nebraska

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : January 2002
  Study Completion Date : November 2003